abstract |
A pharmaceutical composition for topical administration comprising 2,3-dimethyl-6- (N, N-dimethylaminoethyl) -6H- indole- (2,3-b) quinoxaline (B-220) or a pharmaceutically acceptable salt thereof in a pharmaceutically acceptable carrier, for use in the topical treatment of orofacial herpes virus infection in a mammal. |